|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/18 | |
| A61K 39/00 | |||
| A61K 39/12 | |||
| A61K 39/295 | |||
| C12N 7/04 | |||
| C12N 15/86 |
| (11) | Number of the document | 2900687 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13771106.5 |
| Date of filing the European patent application | 2013-09-26 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/070137 |
| Date | 2013-09-26 |
| (87) | Number | WO 2014/049094 |
| Date | 2014-04-03 |
| (30) | Number | Date | Country code |
| 12306176 | 2012-09-27 | EP |
| (72) |
TANGY, Frédéric, FR
BRANDLER, Samantha, AU
DESPRES, Philippe, FR
HABEL, André, DE
|
| (73) |
INSTITUT PASTEUR,
25-28, rue du Docteur Roux, 75724 Paris Cedex 15,
FR
Centre National de la Recherche Scientifique (C.N.R.S.), 3 rue Michel-Ange, 75794 Paris Cedex 16, FR Themis Bioscience GmbH, Muthgasse 11/2, 1190 Vienna, AT |
| (54) | RECOMBINANT MEASLES VIRUS EXPRESSING CHIKUNGUNYA VIRUS POLYPEPTIDES AND THEIR APPLICATIONS |
| RECOMBINANT MEASLES VIRUS EXPRESSING CHIKUNGUNYA VIRUS POLYPEPTIDES AND THEIR APPLICATIONS |